Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down 0.12% Nasdaq Down 0.07%
Streaming
Ticker Tape: On

More On TRABI.BO

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates
  • Research Reports

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Transgene Biotek Ltd. (TRABI.BO)

-BSE

2.09 Up 0.09(4.50%) 4:16AM EDT

Add to Portfolio
Prev Close:2.00
Open:2.10
Bid:2.09
Ask:2.10
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:2.05 - 2.10
52wk Range:1.71 - 30.30
Volume:152,115
Avg Vol (3m):225,464
Market Cap:137.59M
P/E (ttm):0.15
EPS (ttm):13.74
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in INR.

Headlines

  • No Headlines available for TRABI.BO at this time.

Reports

  • No Reports available for TRABI.BO at this time.

Comparison

Symbol% ChgMkt Cap
TRABI.BOUp 4.50%137.59M
PFZ.L 0.00%173.71B
GSK.LDown 0.38%83.07B
AZN.LDown 1.15%41.89B
JNJ.MXUp 0.01%3.00T

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):0.51
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Transgene Biotek Limited engages in the development of bio generic drugs, drug delivery systems, and pharmaceutical products in India. The company’s bio generic products comprise Orlistat, a lipase inhibitor used for obesity management; Tacro... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback